Fundraising FoxWakestream Ventures — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Genetix Biotherapeutics (formerly bluebird bio) develops gene therapies for patients with rare genetic diseases including sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy.
BiotechLongevityMedical DevicesCambridge, US
David Meek(Chief Executive Officer)inBrian Riley(President & Chief Technical Officer)inJoanne Lager(Chief Medical Officer)inWendy DiCicco(Chief Financial Officer)inAdrian Chaisson(Chief of Staff)inJason Cole(Executive Officer)
Co-investorsARCH Venture PartnersEaston CapitalRA CapitalSanofi VenturesThink+ Ventures Management, LlcForbion+1 more
Orbion provides a computational platform for protein engineering that characterizes sequences, ranks stabilizing mutations, predicts construct expression, and generates experimental protocols to filter designs before lab synthesis.
AI & Machine LearningBiotechDeep TechBerlin, DE
Aniruddh Goteti(Co-Founder)inÇağlar Bozkurt(Co-Founder)in
Co-investorsAntlerQAI VenturesAnn Arbor SPARKBeringeaInventus Capital PartnersInvest Detroit+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.